Alphabet Inc Launches A New Firm Isomorphic Labs To Identify Drugs Using AI Technology Of DeepMind
David Hassabis will also take the responsibility of Isomorphic Labs as its CEO during the nascent stage of the newly formed child company, but the two companies (DeepMind and Isomorphic Laboratories) will operate as separate entities and collaborate on the occasions when it is required.